We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biotalys | EU:BTLS | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.06 | 1.97% | 3.10 | 3.01 | 3.10 | 3.14 | 3.04 | 3.05 | 16,214 | 16:40:00 |
North Carolina agriculture investor conferenceNovember 9, 2022Research Triangle Park, NC USAPresentation by Patrice Sellès, CEO of Biotalys
Crop Science Forum & Awards 20222November 10, 2022VirtualBiotalys and its manufacturing partner Olon are finalist in the Award for Best Industry Collaboration
Kepler Cheuvreux Global AgriFood Forum 2022 November 14, 2022VirtualPresentation by Biotalys’ management and 1-2-1 meetings with investors
German Equity ForumNovember 28-30, 2022Frankfurt, GermanyPresentation by company management and 1-2-1 meetings with investors
Canaccord Genuity AgriFood Tech Innovations Forum December 1, 2022VirtualPresentation by company management and 1-2-1 meetings with investors
Biotalys Shareholders Club December 8, 2022Ghent, BelgiumSite visit at Biotalys headquarters for retail investors
Biocontrol & BiomesDecember 13-14, 2022Madrid, Spain (hybrid event)Presentation by Luc Maertens, COO of Biotalys
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company protecting crops and food with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
For further information, please contact
Toon Musschoot, Head of IR & CommunicationT: +32 (0)9 274 54 00E: Toon.Musschoot@biotalys.com
Important Notice
This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words ‘aim’, 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. The Biotalys actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.
Attachments
1 Year Biotalys Chart |
1 Month Biotalys Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions